Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP368686.RAHXQ95yy6sW4MelTX7okO-aLsLOeOkft06uPEz2SJpMU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP368686.RAHXQ95yy6sW4MelTX7okO-aLsLOeOkft06uPEz2SJpMU130_assertion type Assertion NP368686.RAHXQ95yy6sW4MelTX7okO-aLsLOeOkft06uPEz2SJpMU130_head.
- NP368686.RAHXQ95yy6sW4MelTX7okO-aLsLOeOkft06uPEz2SJpMU130_assertion description "[Low grade gliomas are increasingly seen to be divided into two groups based on IDH mutation status, with astrocytomas developing through IDH mutation followed by p53 mutation, while poor prognosis low grade gliomas and primary glioblastomas (GBMs) are characterized by EGFR amplification, loss of PTEN, and loss of cyclin-dependent kinase inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP368686.RAHXQ95yy6sW4MelTX7okO-aLsLOeOkft06uPEz2SJpMU130_provenance.
- NP368686.RAHXQ95yy6sW4MelTX7okO-aLsLOeOkft06uPEz2SJpMU130_assertion evidence source_evidence_literature NP368686.RAHXQ95yy6sW4MelTX7okO-aLsLOeOkft06uPEz2SJpMU130_provenance.
- NP368686.RAHXQ95yy6sW4MelTX7okO-aLsLOeOkft06uPEz2SJpMU130_assertion SIO_000772 25468223 NP368686.RAHXQ95yy6sW4MelTX7okO-aLsLOeOkft06uPEz2SJpMU130_provenance.
- NP368686.RAHXQ95yy6sW4MelTX7okO-aLsLOeOkft06uPEz2SJpMU130_assertion wasDerivedFrom befree-20150227 NP368686.RAHXQ95yy6sW4MelTX7okO-aLsLOeOkft06uPEz2SJpMU130_provenance.
- NP368686.RAHXQ95yy6sW4MelTX7okO-aLsLOeOkft06uPEz2SJpMU130_assertion wasGeneratedBy ECO_0000203 NP368686.RAHXQ95yy6sW4MelTX7okO-aLsLOeOkft06uPEz2SJpMU130_provenance.